Is facial involvement a sign of severe psoriasis?

European Journal of Dermatology

Volumn 18, Issue 2, 2008, Pages 169-171

  Canpolat, Filiz ^a   Cemil, Bengü Çevirgen ^a   Eskioglu, Fatma ^a   Akis, Havva Kaya ^a  

^a MINISTRY OF HEALTH   (Turkey)

Author keywords

Facial involvement; Psoriasis

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE MARKER; DISEASE SEVERITY; FACE; FAMILY HISTORY; FEMALE; HUMAN; JOINT; MAJOR CLINICAL STUDY; MALE; NAIL; ONSET AGE; PATIENT ASSESSMENT; PHOTOTHERAPY; PREVALENCE; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; QUESTIONNAIRE; SKIN;

ADULT; FACIAL DERMATOSES; FEMALE; HUMANS; MALE; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 42349108075     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0363     Document Type: Article

References (17)

1. Saxena VN, Dogra J. Long-term use o penicillin for the treatment of chronic plaque psoriasis. Eur J Dermatol 2005; 15(5): 359-62.
2. Wang G, Li C, Gao T, Liu Y. Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study. Eur J Dermatol 2005; 15(3): 176-8.
3. Fullerton SH, Orenberg EK. Facial involvement as a marker of severe psoriasis. Cutis 1987; 40(4): 309-10.
4. Harrison PV, Walker GB. Facial psoriasis. Clin Exp Dermatol 1985; 10: 41-4.
5. Bernard JD. Facial sparing in psoriasis. Int J Dermatol 1983; 5: 291.
6. Wahl AK, Mork C, Hanestad BR, Helland S. Coping with exacerbation in psoriasis and eczema prior to admission in a dermatological ward. Eur J Dermatol 2006; 16(3): 271-5.
7. Park JY, Rim JH, Choe YB, Youn JI. Facial psoriasis: Comparison of patients with and without facial involvement. J Am Acad Dermatol 2004; 50(4): 582-4.
8. Bernard JD. Facial involvement is a sign of severe psoriasis. In: Farber EM, Nall ML, Morhenn V, eds. Psoriasis: proceedings of the fourth international symposium. New York: Elsevier, 1987: 405-6.
9. Farber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974; 1481: 1-18.
10. Hellegren L. Psoriasis. A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm Venereol 1964; 44: 191-207.
11. Ferrandiz C, Pujol RM, Patos VG, Bordas X, Smandia JO. Psoriasis of early and late onset: A clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002; 46: 863-73.
12. Cardoso CB, Uthida-Tanaka AM, Magalhaes RF, Magna LA, Helena M, Kramer S. Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis. Eur J Dermatol 2005; 15(3): 159-63.
13. Nyfor SA. Psoriasis in children. Characteristics, prognosis and therapy. A review. Acta Derm Venereol 1981; 95(suppl): 47-53.
14. Van De Kerkhof PCM, Kragballe K, Austad J, et al. Psoriasis: severity assessment in clinical practice. Conclusions from workshop discussions and a prospective multicentre survey of psoriasis severity. Eur J Dermatol 2006; 16(2): 167-71.
15. Feng S, Lin L, Wu Q, Zhou W, Shao C. Study on the expression of RXRα in patients with psoriasis vulgaris. Eur J Dermatol 2006; 16(1): 33-8.
16. Melski JE, Bernard JD, Stem RS. The Koebner (isomorphic) response in psoriasis: association with early age of onset and multipl previous therapies. Arch Dermatol 1983; 12: 655-9.
17. Baker AJ, Wilkinson DS. Psoriasis. In: Rook AJ, Wilkinson DS, Ebling FJ, eds. Textbook of dermatology. Oxford: Blackwell Scientific Publications, 1979: 1315.